Altundag K. The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ. Breast Cancer Res Treat 2023 Dec 5. doi: 10.1007/s10549-023-07212.
PMID: 38051408